Global Infectious Disease Diagnostic Market to Reach $39.9 Billion by 2030: Allied Market Research

Increase in prevalence of infection disease, rise in demand for point-of-care diagnostic testing, and surge in number of medical laboratories drive the growth of the global infectious disease diagnostic market. However, the outbreak of the COVID-19 pandemic have had a positive impact the global infectious disease diagnostic market, owing to the increased need for the development of diagnostic instruments and diagnostic service centers.

/EIN News/ -- Portland, OR, Oct. 14, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Infectious Disease Diagnostic Market generated $23.3 billion in 2020, and is projected to reach $39.9 billion by 2030, witnessing a CAGR of 6.8% from 2021 to 2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/2011

Increase in prevalence of infection disease, rise in demand for point-of-care diagnostic testing, surge in number of medical laboratories, and growth in awareness among individuals regarding early diagnosis detection drive the growth of the global infectious disease diagnostic market. However, high cost of diagnostic instruments and lack of skilled professional & trained personnel restrain the market to some extent. On the other hand, increase in development of advanced diagnostic devices by major key players presents new opportunities in the upcoming years.

COVID-19 scenario:

• The outbreak of the COVID-19 pandemic has had a positive impact the global infectious disease diagnostic market, owing to the increased need for the development of diagnostic instruments and diagnostic service centers.
• Rise in number of COVID-19 cases surged the demand for real time polymerase chain reactions, thus boosting the growth of the global infectious disease diagnostic market.
• For instance, in March 2020, Abbott, a global healthcare company, announced the launch of Abbott ID NOW COVID-19 test, which is a molecular point-of-care test used to detect COVID-19 in as little as 5 minutes.

The report offers detailed segmentation of the global infectious disease diagnostic market based on product, disease type, technology, and region.

Based on product, the assays and reagents segment held the highest market share in 2020, holding nearly three-fifths of the total market share, and is expected to continue its leadership status during the forecast period. Moreover, the instruments segment is estimated to register the highest CAGR of 8.1% from 2021 to 2030.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2011

Based on disease type, the hepatitis segment held the largest market share in 2020, holding nearly one-fourth of the total market share, and is expected to continue its leadership status during the forecast period. Moreover, the same segment is projected to register the highest CAGR of 9.0% from 2021 to 2030, while influenza registered the CAGR of 7.6% from 2021 to 2030.

Based on region, the global antipsychotic drugs market across North America contributed to the highest share in terms of revenue in 2020, holding nearly two-fifths of the total market share, and is estimated to continue its dominant share by 2030. However, Asia-Pacific is projected to manifest the fastest CAGR of 8.5% during the forecast period.

Leading players of the global infectious disease diagnostic market analyzed in the research include Abbott Laboratories, Becton Dickinson and Company, BioMerieus SA, Bio-Rad Laboratories, Danaher Corporation, F Hoffman-La Roche, Hologic Inc., Luminex Corporation, Qiagen Inc., and Thermo Fisher Scientific Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

mHealth Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Biopsy Devices Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

EEG Equipment Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

COPD and Asthma Devices Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Opioids Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Advanced Wound Care Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

In Vitro Diagnostics (IVD) Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Sleep Aids Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Surgical Robotics Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Medical Spa Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
                    
                    David Correa
                    5933 NE Win Sivers Drive
                    #205, Portland, OR 97220
                    United States
                    USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
                    UK: +44-845-528-1300
                    Hong Kong: +852-301-84916
                    India (Pune): +91-20-66346060
                    Fax: +1(855)550-5975
                    help@alliedmarketresearch.com
                    Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
                    Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/